Innovative CRO+  Explorer focuses on target based lead compound screening and optimization, as well as new drug discovery services for the central nervous system and cardiovascular system. The company has built targets and screening technologies for new drug screening in batches, including drug screening and early drug evaluation platforms for more than 400 kinases, more than 100 ion channels, more than 100 G-protein-coupled receptors and more than 40 nuclear receptor targets.